Eufenil

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Eufenil

Quick Facts

Property Description
Active ingredient Ibuprofen (Isobutylpropanoic acid)
Form Oral tablets, capsules, suspension
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
General purpose Reduction of pain, fever, and inflammation
Origin Synthetic compound (Propionic acid derivative)

What Type of Medicine Is Eufenil and What Is Its Active Ingredient?

Eufenil is a synthetic pharmaceutical whose active ingredient is Ibuprofen, officially classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). Ibuprofen is chemically identified as a propionic acid derivative and functions as a single-ingredient product utilized for systemic relief. This classification is clinically recognized for its broad application in managing general discomfort. For instance, the active ingredient is frequently used to address muscle aches or temporary fevers, and is defined as an antipyretic and analgesic. As a drug widely available for self-management, its status as a foundational NSAID is critical for understanding its role in the pharmacological landscape.

What Is the General Purpose of Eufenil?

The general purpose of Eufenil is to provide symptomatic relief by concurrently reducing three key bodily manifestations: pain, fever, and inflammation. This action is achieved because Ibuprofen functions as a Cyclooxygenase (COX) inhibitor, which interrupts the chemical synthesis pathway responsible for producing prostaglandins, the mediators of these symptoms. The primary benefit is the combined effect of its analgesic property (reducing pain), its antipyretic property (lowering fever), and its anti-inflammatory property (reducing swelling). The overall benefit is a targeted reduction in the core symptoms of discomfort and systemic heat.

What Forms Is Eufenil Available In?

The medicine containing Ibuprofen is provided in several pharmaceutical preparations to facilitate its primary oral route of administration. These preparations commonly include standard forms such as oral tablets, capsules, and oral suspension. These diverse forms are manufactured with various pharmaceutical excipients to ensure effective delivery and absorption of the active substance, making the drug highly versatile across different patient groups.

What side effects are possible with Eufenil ?

Possible Side Effects and Safety Information

The official safety profile for Eufenil, which contains Ibuprofen, is structured around categories defined by global regulatory agencies to communicate both common, expected adverse effects and rare, serious safety constraints. The classification of adverse reactions is based on frequency and the System-Organ Class (SOC) affected.


Adverse Reaction Scope

Classification Examples of Officially Listed Effects
Common Adverse Reactions Typically include Gastrointestinal Disorders (e.g., dyspepsia, nausea, abdominal pain) and Nervous System Disorders (e.g., headache, dizziness).
Serious Adverse Reactions Officially documented risks include serious Cardiovascular Thrombotic Events (such as myocardial infarction and stroke) and severe Gastrointestinal Events (bleeding, ulceration, and perforation). Severe allergic reactions like Stevens-Johnson Syndrome are classified as rare.

Safety Constraints and Considerations

Regulatory documentation defines specific constraints and cautions tied to the medicine's use. The risk of serious Cardiovascular and Gastrointestinal events is officially noted as being higher with prolonged use or at higher doses.

Specific patient populations have safety considerations. Older adults are documented as having an increased risk for serious consequences from adverse reactions, particularly gastrointestinal events. The use of Ibuprofen is officially contraindicated in the third trimester of pregnancy and for patients with active peptic ulceration, a history of bleeding, or severe heart failure.

Overdose and Emergency Response

Eufenil Overdose and When to Seek Help

The official overdose profile for Eufenil (Ibuprofen) is defined by documented clinical findings and mandated emergency response actions specified in regulatory labeling.

Overdose may initially present with common signs such as nausea, vomiting, abdominal pain, and drowsiness. Severe cases, as described in official documents, may escalate to serious Central Nervous System (CNS) effects, including convulsions (seizures) and coma, along with profound metabolic acidosis.

Documented Severe Outcomes
Acute renal failure or kidney injury
Significant GI bleeding, ulceration, or perforation
Hypotension (low blood pressure)

The regulatory mandate requires that patients seek medical help right away or contact a Poison Control Center right away if an overdose is suspected. This is critical because no specific antidote is known for Ibuprofen overexposure. Management is defined strictly as symptomatic and supportive treatment, which may include the use of activated charcoal or gastric lavage under clinical supervision.

The official label notes that elderly patients and individuals with existing renal impairment face an increased risk for serious and potentially fatal consequences following overdose.

Therapeutic Uses of Eufenil

What Eufenil Treats: Main Uses and Benefits

Eufenil is commonly used in situations involving certain distressing symptoms, applied across domains where additional symptomatic support is needed. It is commonly used for managing symptoms associated with three key domains of general discomfort: pain, fever, and inflammation.


Easing Discomfort and Managing Acute and Episodic Symptoms

Eufenil is relevant for managing symptoms related to physical discomfort and systemic imbalance, typically used when short-term assistance is appropriate for mild to moderate pain. It is commonly used for conditions presenting with acute episodes, helping address symptom clusters such as headaches, dental pain, muscle aches, the discomfort of menstrual cramps (dysmenorrhea), and the pain and fever associated with the common cold or influenza.

“It supports patients during episodes of heightened discomfort and may assist with maintaining functional stability in situations involving inflammatory or irritative processes.”

This application provides supportive relief when symptoms interfere with routine activities, contributing to improved comfort during symptomatic periods. The medication is applied in conditions involving inflammatory or irritative processes, such as localized swelling and tenderness from minor injuries or in chronic conditions like osteoarthritis and rheumatoid arthritis flares.

Quick Fact: Relief for Inflammation
Eufenil is commonly used to address symptoms associated with musculoskeletal issues, including swelling and pain from minor sprains and strains.

Regulatory References

  1. MedlinePlus Drug Information on Ibuprofen

Eligibility and Restrictions for Use

Eufenil, which contains ibuprofen, is generally used to relieve mild to moderate pain from conditions like headaches, menstrual cramps, dental pain, and musculoskeletal issues, as well as to reduce fever and inflammation associated with various conditions, including arthritis.

Who Can Use Eufenil?

  • Most adults and children over 12 years of age can use Eufenil for temporary relief of pain and fever. Specific pediatric formulations may be suitable for children as young as three months, but usage should follow specialized guidance.
  • It is often used for conditions such as osteoarthritis and rheumatoid arthritis under medical supervision.

Who Should NOT Use Eufenil (Contraindications)?

Certain conditions increase the risk of serious side effects with ibuprofen. Eufenil is generally contraindicated for individuals with:

Condition
A known allergy to ibuprofen, aspirin, or other NSAIDs
Active stomach or intestinal ulcers or a history of recurrent peptic ulcers/bleeding
Severe heart failure or shortly before/after heart bypass surgery (CABG)
Severe kidney or liver disease
Late-stage pregnancy (third trimester)
Blood clotting disorders or while taking anticoagulant medication (due to increased bleeding risk)

Consult a healthcare provider before use if you have a history of asthma (especially aspirin-sensitive asthma), high blood pressure, fluid retention, or are taking other NSAIDs or corticosteroids.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Eufenil (Ibuprofen) has officially documented interaction patterns primarily concerning pharmacodynamic effects and altered substance exposure. Co-administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) or high-dose Acetylsalicylic Acid (Aspirin) is discouraged due to the increased risk of adverse reactions.

Documented Pharmacodynamic and Exposure Interactions

Interaction Type Interacting Substance/Class Official Interaction Outcome
Pharmacodynamic Anticoagulants (e.g., Warfarin) Enhanced risk of severe bleeding.
Pharmacodynamic Oral Corticosteroids Increased risk of gastrointestinal bleeding.
Exposure Modification Lithium and Methotrexate Reduced renal clearance leading to increased plasma concentrations.
Pharmacodynamic Antihypertensives ( ACE inhibitors, Diuretics) Diminution of therapeutic efficacy.

Timing and Condition Restrictions

Use is contraindicated for the treatment of peri-operative pain in the setting of Coronary Artery Bypass Graft ( CABG) surgery. When taking low-dose Aspirin, Ibuprofen must be administered at least 8 hours before or 30 minutes after the immediate-release Aspirin dose to mitigate interference with its anti-platelet effect. Additionally, co-administration with Alcohol (Ethanol) is associated with an increased risk of gastrointestinal bleeding.

Mechanism of Action

The Mechanism of Eicosanoid Inhibition

Eufenil's action is defined by its intervention in the eicosanoid pathway. The molecule functions as a non-selective competitive inhibitor of Cyclooxygenase (COX) enzymes, specifically binding to the active sites of both COX-1 and COX-2 isoforms. This interaction blocks the conversion of arachidonic acid into prostaglandins and thromboxanes, halting the synthesis of these key lipid mediators at the molecular level.

This core mechanism translates into two distinct physiological modulations. Peripherally, the suppression of prostaglandin production decreases local vasodilation and reduces nociceptor sensitization in injured tissues. Centrally, the inhibition of prostaglandin synthesis within the hypothalamus modifies the body's thermoregulatory set-point, resulting in the adjustment of core body temperature (antipyresis). This combined central and peripheral activity characterizes the drug's overall pharmacodynamic profile.

Dosage and Administration Information

How Eufenil Is Used

Administration of Eufenil, which contains the active ingredient Ibuprofen, follows specific principles regarding route, dosing, and schedule.


Official Administration Protocol

Instruction Description
Route of Administration The primary route is Oral (tablets, capsules, or suspension). It is also used for Intravenous (IV) Infusion for certain uses in controlled clinical settings.
Standard Dosing Range Adult Prescription Maintenance: 1200 mg to 3200 mg total daily dose, administered in divisions. The Maximum Daily Dose for non-prescription (OTC) use is 1200 mg.
Frequency and Timing Doses are typically taken every 4 to 6 hours as needed, or in divided doses three to four times daily for maintenance therapy. It is generally advised to take the medicine with food or milk to reduce the chance of gastric discomfort.

Usage Constraints and Population-Specific Rules

Usage protocols impose specific constraints on administration. The medicine is intended for use at the lowest effective dose for the shortest possible duration. For older adults, guidance involves using the lowest effective dose with increased clinical monitoring. Pediatric dosing is governed by weight-based calculations (e.g., 5 to 10 mg/kg per dose) and must not exceed specific daily limits.

Special Conditions apply to certain forms: the IV Infusion requires professional dilution and must be administered slowly, typically over a 10 to 30 minute period, and extended-release forms must be swallowed whole without crushing. If a dose is missed, guidance advises against doubling the subsequent dose.

Recent Clinical Evidence

Eufenil: Recent Clinical Evidence

Clinical research involving Eufenil has largely focused on its use in managing mild-to-moderate pain, as well as symptoms associated with conditions such as osteoarthritis and certain types of headache. The available evidence for Eufenil is primarily derived from randomized, controlled trials (RCTs) that compare the medication against a placebo or other active treatments.

Efficacy Data

Studies investigating the effect of a standard dose of Eufenil on acute pain, such as dental or musculoskeletal discomfort, observed a measurable reduction in pain intensity scores for participants receiving Eufenil compared to those receiving placebo. Analysis of clinical trial data suggests that for a single dose, the proportion of patients reporting at least a 50% reduction in pain over a set time period was consistently higher in the Eufenil groups.

Comparative Findings

Comparative studies, including those for postoperative dental pain, have explored Eufenil's effect in combination with other analgesics. One Phase III trial noted that a fixed-dose combination involving Eufenil was associated with a greater and potentially faster onset of pain relief compared to Eufenil monotherapy or a second single-agent analgesic. Evidence also indicates that the response to Eufenil for acute pain does not appear to differ significantly between male and female adult populations.

Safety Profile and Potential Risks

As with all medications, use of Eufenil is associated with certain risks. Clinical data reports the most common adverse events include gastrointestinal symptoms such as nausea, heartburn, and abdominal pain. More serious risks identified in research, particularly with prolonged or high-dose use, relate to potential cardiovascular events (such as increased risk of heart attack or stroke) and gastrointestinal bleeding or ulceration. Patients with pre-existing conditions, including heart disease, high blood pressure, or a history of stomach ulcers, may require careful medical consideration before use.

Frequently Asked Questions (FAQ)

Common questions about Eufenil (FAQ)

Q: Does Eufenil make you sleepy, and should I take it before bed?

The official prescribing information for Eufenil commonly notes that it may cause drowsiness or sedation. This effect is why it may be prescribed to assist with sleep in certain situations.

To minimize the potential for daytime drowsiness, the prescribing information commonly advises that the dose be taken close to bedtime.

If a dose is missed, product labeling often recommends consulting a healthcare provider for guidance, and typically advises against taking two doses at once.

Q: Can I drink alcohol while taking Eufenil?

Official prescribing information strongly advises against consuming alcohol while taking Eufenil.

Both Eufenil and alcohol can cause central nervous system depression, such as drowsiness and impaired alertness. The combination may significantly increase the potential for these side effects, including severe sedation and respiratory depression.

Q: Is Eufenil an addictive drug?

Eufenil is generally not classified as an addictive drug in the same way as controlled substances. However, individuals who have been taking it consistently may develop a physical dependence.

Due to this, abruptly stopping Eufenil is generally advised against, as it may lead to withdrawal symptoms.

To support safe discontinuation, a healthcare provider should be consulted before stopping Eufenil, as the official labeling recommends a gradual reduction in dosage over time.

How should Eufenil be stored and disposed of?

How to Store and Dispose of Eufenil?

The official storage and disposal requirements for Eufenil (Ibuprofen) are defined by regulatory documents to maintain its stability and ensure environmental safety.

Storage Requirement Official Instruction
Temperature Store at or below 25 C or 30 C (depending on the formulation).
Protection Keep protected from light and moisture.
Packaging Must remain in the original outer carton or container.
Child Safety Store out of the sight and reach of children.
Disposal Do not flush down the sink or toilet.

Disposal of unused or expired Eufenil must strictly follow local pharmaceutical waste regulations. The product should be returned to a pharmacist or a designated drug take-back location. Environmental protection warnings in certain labels mandate this controlled disposal method.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Eufenil  found in:

A-Z Index: